The role of genetic sequencing and analysis in the polio eradication programme
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Genetic sequencing of polioviruses detected through clinical and environmental surveillance is used to confirm detection, identify their likely origin, track geographic patterns of spread, and determine the appropriate vaccination response. The critical importance of genetic sequencing and analysis to the Global Polio Eradication Initiative has grown with the increasing incidence of vaccine-derived poliovirus (VDPV) infections in Africa specifically (470 reported cases in 2019), and globally, alongside persistent transmission of serotype 1 wild-type poliovirus in Pakistan and Afghanistan (197 reported cases in 2019). Adapting what has been learned about the virus genetics and evolution to address these threats has been a major focus of recent work. Here, we review how phylogenetic and phylogeographic methods have been used to trace the spread of wild-type polioviruses and identify the likely origins of VDPVs. We highlight the analysis methods and sequencing technology currently used and the potential for new technologies to speed up poliovirus detection and the interpretation of genetic data. At a pivotal point in the eradication campaign with the threat of anti-vaccine sentiment and donor and public fatigue, innovation is critical to maintain drive and overcome the last remaining circulating virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A number of studies have identified three specific codon positions that are involved in this reversion, two in the 5′ UTR region and one in the VP1 region [82,83].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been shown that cVDPV strains are recombinant. Indeed, their genome consists of a capsid protein-coding region from the vaccine strain, while the non-structural protein-coding region—and sometimes one or both non-coding regions—is from other enteroviruses of the same Enterovirus C species [83].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Primary structure, gene organization and polypeptide expression of poliovirus RNA
Kitamura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R., Lee, J. J., van der Werf, S., et al. (1981) · Nature · doi:10.1038/291547a0 · Cited by 914
Oberste, M. S., Maher, K., Kilpatrick, D. R., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1941-1948.1999 · Cited by 866
Enders, J. F., Weller, T. H., & Robbins, F. C. (1949) · Science · doi:10.1126/science.109.2822.85 · Cited by 749
Racaniello, V. R., & Baltimore, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4887 · Cited by 550
Virus genomes reveal factors that spread and sustained the Ebola epidemic
Dudas, G., Carvalho, L. M., Bedford, T., Tatem, A. J., Baele, G., Faria, N. R., Park, D. J., Ladner, J. T., Arias, A., Asogun, D., et al. (2017) · Nature · doi:10.1038/nature22040 · Cited by 405
Lemey, P., Rambaut, A., Bedford, T., Faria, N., Bielejec, F., Baele, G., Russell, C. A., Smith, D. J., Pybus, O. G., Brockmann, D., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003932 · Cited by 397
Metagenomic Analyses of Viruses in Stool Samples from Children with Acute Flaccid Paralysis
Victoria, J. G., Kapoor, A., Li, L., Blinkova, O., Slikas, B., Wang, C., Naeem, A., Zaidi, S., & Delwart, E. (2009) · Journal of Virology · doi:10.1128/jvi.02301-08 · Cited by 375
Polio vaccination: Past, present and future
Bandyopadhyay, A. S., Garon, J., Seib, K., & Orenstein, W. A. (2015) · Future Microbiology · doi:10.2217/fmb.15.19 · Cited by 276
Salk, J. E., Bennett, B. L., Lewis, L. J., Ward, E. N., & Youngner, J. S. (1953) · Journal of the American Medical Association · doi:10.1001/jama.1953.13.1081 · Cited by 218
Location and primary structure of a major antigenic site for poliovirus neutralization
Minor, P. D., Schild, G. C., Bootman, J., Evans, D. M. A., Ferguson, M., Reeve, P., Spitz, M., Stanway, G., Cann, A. J., Hauptmann, R., et al. (1983) · Nature · doi:10.1038/301674a0 · Cited by 194
Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
Identification of two determinants that attenuate vaccine-related type 2 poliovirus
Ren, R. B., Moss, E. G., & Racaniello, V. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1377-1382.1991 · Cited by 163
Macklin, G., O’Reilly, K. M., Grassly, N. C., Edmunds, W. J., Mach, O., Krishnan, R. S. G., Voorman, A., Vertefeuille, J. F., Abdelwahab, J., Gumede, N., et al. (2020) · Science · doi:10.1126/science.aba1238 · Cited by 156
Self-citationBurns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Convergent Bacterial Microbiotas in the Fungal Agricultural Systems of Insects
Aylward, F. O., Suen, G., Biedermann, P. H. W., Adams, A. S., Scott, J. J., Malfatti, S. A., Glavina del Rio, T., Tringe, S. G., Poulsen, M., Raffa, K. F., et al. (2014) · mBio · doi:10.1128/mbio.02077-14 · Cited by 144
Van Damme, P., De Coster, I., Bandyopadhyay, A. S., Revets, H., Withanage, K., De Smedt, P., Suykens, L., Oberste, M. S., Weldon, W. C., Costa-Clemens, S. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31279-6 · Cited by 141
Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138
Implications of a circulating vaccine-derived poliovirus in Nigeria
Jenkins, H. E., Aylward, R. B., Gasasira, A., Donnelly, C. A., Mwanza, M., Corander, J., Garnier, S., Chauvin, C., Abanida, E., Pate, M. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910074 · Cited by 131
Self-citationThe Evolutionary Pathway to Virulence of an RNA Virus
Stern, A., Yeh, M. T., Zinger, T., Smith, M., Wright, C., Ling, G., Nielsen, R., Macadam, A., & Andino, R. (2017) · Cell · doi:10.1016/j.cell.2017.03.013 · Cited by 127
Jegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
Dunn, G., Klapsa, D., Wilton, T., Stone, L., Minor, P. D., & Martín, J. E.-S. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005114 · Cited by 114
PRESENT STATUS OF ATTENUATED LIVE-VIRUS POLIOMYELITIS VACCINE
Sabin, A. B. (1956) · JAMA · doi:10.1001/jama.1956.02970350005002 · Cited by 107 · cited 1×
“With in vitro poliovirus growth a possibility, and knowledge of the three serotypes, successful development of inactivated poliovirus vaccine (IPV) and live-attenuated oral poliovirus vaccine (OPV) followed in 1953 and 1956, respectively (Salk 1953; Sabin 1956).”
BackgroundMacadam, A. I., Pollard, S., Ferguson, G. L., Dunn, G., Skuce, R., Almond, J. W., & Minor, P. D. (1991) · Virology · doi:10.1016/0042-6822(91)90877-e · Cited by 105
The Biologic Principles of Poliovirus Eradication
Dowdle, W. R., & Birmingham, M. E. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s286 · Cited by 99 · cited 1×
“Poliovirus survival in the environment is highly variable, with a 90 per cent infectivity loss observed in 26 days in sewage at 23 C (Dowdle and Birmingham 1997).”
BackgroundUpdate on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2018–June 2019
Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Quddus, A., Sutter, R., Vertefeuille, J. F., Wenger, J., Wassilak, S. G. F., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6845a4 · Cited by 83
Famulare, M., Chang, S. T., Iber, J. C., Zhao, K., Adeniji, J. A., Bukbuk, D. N., Baba, M., Behrend, M. R., Burns, C. C., & Oberste, M. S. (2015) · Journal of Virology · doi:10.1128/jvi.01532-15 · Cited by 82
Progress Toward Polio Eradication — Worldwide, January 2017–March 2019
Greene, S. A., Ahmed, J., Datta, S., Burns, C. C., Quddus, A., Vertefeuille, J. F., & Wassilak, S. G. F. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6820a3 · Cited by 80
Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine
Blake, I. M., Pons-Salort, M., Molodecky, N. A., Diop, O. M., Chenoweth, P., Bandyopadhyay, A. S., Zaffran, M., Sutter, R. W., & Grassly, N. C. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716677 · Cited by 79
Self-citationIdentification of vaccine-related polioviruses by hybridization with specific RNA probes
De, L., Nottay, B. K., Yang, C. F., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.562-571.1995 · Cited by 77
Poliovirus serotype-specific VP1 sequencing primers
Kilpatrick, D. R., Iber, J. C., Chen, Q., Ching, K., Yang, S.-J., De, L., Mandelbaum, M., Emery, B. D., Campagnoli, R. P., Burns, C. C., et al. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.03.020 · Cited by 75
Tambini, G., Andrus, J. K., Marques, E., Boshell, J., Pallansch, M. A., de Quadros, O. A., & Kew, O. M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.6.1510 · Cited by 75
DIFFERENTIATION OF TYPES OF POLIOMYELITIS VIRUSES
Bodian, D., Morgan, I. M., & Howe, H. A. (1949) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119273 · Cited by 74 · cited 1×
“1 Foundation of Infantile Paralysis (USA) in 1951 (Bodian, Morgan, and Howe 1949; Committee on Typing of National Foundation of Infantile Paralysis 1951).”
BackgroundGrassly, N. C. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit601 · Cited by 72 · cited 1×
“However, a single dose of IPV results in seroconversion in just 50 80 per cent of children (depending on the age at administration; Grassly 2014; Bandyopadhyay et al. 2018) and its delayed introduction as a result of supply shortages and limited coverage has resulted in a growing cohort of children…”
BackgroundSelf-citationIdentification and Manipulation of the Molecular Determinants Influencing Poliovirus Recombination
Runckel, C., Westesson, O., Andino, R., & DeRisi, J. L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003164 · Cited by 69
Holmblat, B., Jégouic, S., Muslin, C., Blondel, B., Joffret, M., & Delpeyroux, F. (2014) · mBio · doi:10.1128/mbio.01119-14 · Cited by 62
The 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt
Yakovenko, M. L., Gmyl, A. P., Ivanova, O. E., Eremeeva, T. P., Ap, I., Prostova, M. A., Baykova, O. Y., Isaeva, O. V., Lipskaya, G. Y., Shakaryan, A. K., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.7.20706 · Cited by 60
Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
Pons-Salort, M., Burns, C. C., Lyons, H. M., Blake, I. M., Jafari, H. S., Oberste, M. S., Kew, O. M., & Grassly, N. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005728 · Cited by 60
Self-citationIsolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine
Zurbriggen, S., Tobler, K., Abril, C. E., Diedrich, S., Ackermann, M., Pallansch, M. A., & Metzler, A. E. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02764-07 · Cited by 59
DIFFERENTIATION OF TYPES OF POLIOMYELITIS VIRUSES
Bodian, D. (1949) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119271 · Cited by 56
Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor
Chen, Z., Fischer, E. R., Kouiavskaia, D. V., Hansen, B. T., Ludtke, S. J., Bidzhieva, B., Makiya, M. A., Agulto, L., Purcell, R. H., & Chumakov, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320041110 · Cited by 55
Genetic recombination of poliovirus in a cell-free system
Duggal, R., Cuconati, A., Gromeier, M., & Wimmer, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13786 · Cited by 50
Bessaud, M., Joffret, M., Blondel, B., & Delpeyroux, F. (2016) · Scientific Reports · doi:10.1038/srep38831 · Cited by 49
Cowger, T. L., Burns, C. C., Sharif, S., Gary, H. E., Iber, J. C., Henderson, E., Malik, F., Zaidi, S. S. Z., Shaukat, S., Rehman, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180608 · Cited by 48
Assessing the sensitivity of the polio environmental surveillance system
Kroiss, S. J., Ahmadzai, M., Ahmed, J., Alam, M. M., Chabot‐Couture, G., Famulare, M., Mahamud, A. S., McCarthy, K. A., Mercer, L. D., Salman, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208336 · Cited by 46
Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas — Nigeria, 2016
Nnadi, C. D., Damisa, E., Esapa, L., Braka, F., Waziri, N., Siddique, A. R., Jorba, J. C., wa, G., Nganda, Ohuabunwo, C. J., et al. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6607a2 · Cited by 44
Knowlson, S., Burlison, J., Giles, E., Fox, H., Macadam, A. J., & Minor, P. D. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005316 · Cited by 39
Bandyopadhyay, A. S., Modlin, J. F., Wenger, J. D., & Gast, C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy633 · Cited by 36
O’Reilly, K. M., Verity, R., Durry, E., Asghar, H., Sharif, S., Zaidi, S., Wadood, M. Z., Diop, O. M., Okayasu, H., Safdar, R. M., et al. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3070-4 · Cited by 33
Self-citationYang, J., Müller, N. F., Bouckaert, R., Xu, B., & Drummond, A. J. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007189 · Cited by 32
Isolation of Vaccine-Like Poliovirus Strains in Sewage Samples From the United Kingdom
Majumdar, M., Klapsa, D., Wilton, T., Akello, J. O., Anscombe, C., Allen, D. J., Mee, E. T., Minor, P. D., & Martín, J. E.-S. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix667 · Cited by 29
Korotkova, E. A., Gmyl, A. P., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Kozlovskaya, L. I., Shakaryan, A. K., Lipskaya, G. Y., Parshina, I. L., Loginovskikh, N. V., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00277-16 · Cited by 23
Pons-Salort, M., Molodecky, N. A., O’Reilly, K. M., Wadood, M. Z., Safdar, R. M., Etsano, A., Vaz, R. G., Jafari, H. S., Grassly, N. C., & Blake, I. M. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002140 · Cited by 23
Self-citationPoliovirus proves IRES-istible in vivo
Semler, B. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22139 · Cited by 22
Shaw, J., Jorba, J. C., Zhao, K., Iber, J. C., Chen, Q., Adu, F., Adeniji, J. A., Bukbuk, D. N., Baba, M., Henderson, E., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01949-17 · Cited by 21
Akhtar, R., Mahmood, N., Alam, M. M., Naeem, M., Zaidi, S. S. Z., Sharif, S., Khattak, Z., Arshad, Y., Khurshid, A., Mujtaba, G., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1037 · Cited by 14
BODIAN, D. (1951) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119476 · Cited by 13
Phylogenetic Analysis of Poliovirus Sequences
Jorba, J. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3292-4_11 · Cited by 11 · cited 1×
“New clusters are added whenever a detected VP1 sequence is 5 per cent divergent from previously collected samples (Jorba 2016).”
BackgroundPolio returns to the Philippines
Thornton, J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32263-9 · Cited by 10 · cited 1×
“3) (World Health Organization 2014c; Greene et al. 2019; Thornton 2019).”
BackgroundThe moral dilemma of the polio eradication programme
John, T., & Dharmapalan, D. (2019) · Indian Journal of Medical Ethics · doi:10.20529/ijme.2019.060 · Cited by 5 · cited 1×
“With a cheap, effective, and orally administered vaccine available and a virus with no known animal reservoir, eradication seemed like an imminent possibility when the GPEI was launched (World Health Organization 1988; John and Dharmapalan 2019).”
BackgroundKoch‐Nolte, F., & Koch, G. (1985) · Springer eBooks · doi:10.1007/978-3-7091-7000-7_1 · Cited by 4
Research works printed but not linked: 7
- 1987, Fourth Meeting of the EPI Technical Advisory Group (TAG) on Eradiaction of Poliomyelitis in the Americas
- 2006, Poliomyelitis Eradication Field Guide
- 2003, Guidelines for Environmental Surveillance of Poliovirus Circulation
- 1988, Forty-First World Health Assembly, Geneva
- 2004, Polio Laboratory Manual
- 2014, WHO Statement on the Second Meeting of the International Health Regulations Emergency Committee Concerning the International Spread of Wild Poliovirus
- 2019, Global Polio Surveillance Action Plan, 2018 − 2020
Cited by
Advancing pathogen genomics in resource-limited settings
Pronyk, P., de Alwis, R., Rockett, R. J., Basile, K., Boucher, Y., Pang, V., Sessions, O. M., Getchell, M., Golubchik, T., Lam, C., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100443 · Cited by 104
“80 Finally, metagenomics on environmental samples has been identified as a new approach to identify and characterize unknown potential pathogens before they emerge.”
BackgroundNext-Generation Sequencing for Confronting Virus Pandemics
Quer, J., Colomer‐Castell, S., de Campos, C. F., Andrés, C., Piñana, M., Cortese, M. F., Gónzalez‐Sánchez, A., García‐Cehic, D., Ibañez‐Lligoña, M., Pumarola, T., et al. (2022) · Viruses · doi:10.3390/v14030600 · Cited by 82
“Poliovirus sequencing is currently performed to identify the virus, detect genetic features such as recombinant events in addition to genetic drift, propose the likely origin, track geographic patterns of spread, and determine the appropriate vaccination response [25].”
BackgroundShaw, A., Majumdar, M., Troman, C. M., O’Toole, Á., Benny, B., Abraham, D., Praharaj, I., Kang, G., Sharif, S., Alam, M. M., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00920-20 · Cited by 66
Self-citationThe Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
“This instability is caused by the lack of a corrective function in RNA-dependent RNA polymerase, leading to point mutations occurring [83,84].”
BackgroundUzzell, C. B., Troman, C. M., Rigby, J., Mohan, V. R., John, J. K., Abraham, D., Srinivasan, R., Nair, S., Meschke, J. S., Elviss, N. C., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17687.1 · Cited by 27
Self-citation
Metadata
- Authors
- Jorgensen, D., Pons-Salort, M., Shaw, A. G., & Grassly, N. C.
- Affiliations
- Imperial College London (GB)
- Department of Infectious Disease Epidemiology, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK
- Corresponding author
- Jorgensen, David
- Venue
- Virus Evolution
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-20
- Volume
- 6
- Issue
- 2
- Pages
- veaa040-veaa040
- ISSN
- 2057-1577 (ISSN-L)
- PMC
- PMC7409915
- OpenAlex
- W3028178982
- Cited by
- 31
- References
- 61
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 7 · 2022: 6 · 2021: 3 · 2020: 1
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Virus Evolution (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Medical Research Council
- Wellcome Trust
- Royal Society
- Engineering and Physical Sciences Research Council
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- poliovirus, polio eradication, vaccine-derived poliovirus, wild-type poliovirus, phylogenetics, phylogeography, gene sequencing, environmental surveillance, vaccine response, sequencing technologies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.